Dexter Pratt

Dexter Pratt

Auto-generated profile, based on publicly available information

Dexter Pratt

Department of Medicine, University of California San Diego, La Jolla, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Cell Systems
Verified
Journal Article
Closed access
DPDexter Pratt
Dexter Pratt
JCJing Chen
Jing Chen
DWDavid Welker
David Welker
RRRicardo Rivas
Ricardo Rivas
RPRudolf Pillich
Rudolf Pillich
TITrey Ideker
Trey Ideker

28 November 2024 in Nature Methods
Verified
Journal Article
Closed access
PDF file
MHMengzhou Hu
Mengzhou Hu
SASahar Alkhairy
Sahar Alkhairy
ILIngoo Lee
Ingoo Lee
RPRudolf T. Pillich
Rudolf T. Pillich
DFDylan Fong
Dylan Fong
DPDexter Pratt
Dexter Pratt

1 October 2021 in Science
Verified
Journal Article
Closed access
FZFan Zheng
Fan Zheng
MKMarcus R. Kelly
Marcus R. Kelly
DRDana J. Ramms
Dana J. Ramms
MHMarissa L. Heintschel
Marissa L. Heintschel
KTKai Tao
Kai Tao
TITrey Ideker
Trey Ideker
Mapping protein interactions driving cancer: Cancer is a genetic disease, and much cancer research is focused on identifying carcinogenic mutations and determining how they relate to disease progression. Three papers demonstrate how mutations are processed through networks of protein interactions to promote cancer (see the Perspective by Cheng and Jackson). Swaney et al . focus on head and neck cancer and identify cancer-enriched interactions, demonstrating how point mutant–dependent interactions of PIK3CA, a kinase frequently mutated in human cancers, are predictive of drug response. Kim et al . focus on breast cancer and identify two proteins functionally connected to the tumor-suppressor gene BRCA1 and two proteins that regulate PIK3CA. Zheng et al . developed a statistical model that identifies protein networks that are under mutation pressure across different cancer types, including a complex bringing together PIK3CA with actomyosin proteins. These papers provide a resource that will be helpful in interpreting cancer genomic data. —VV

31 October 2017 in Cancer Research
Verified
Journal Article
Closed access
PDF file
DPDexter Pratt
Dexter Pratt
JCJing Chen
Jing Chen
RPRudolf Pillich
Rudolf Pillich
VRVladimir Rynkov
Vladimir Rynkov
AGAaron Gary
Aaron Gary
TITrey Ideker
Trey Ideker
We present NDEx 2.0, the latest release of the Network Data Exchange (NDEx) online data commons (www.ndexbio.org) and the ways in which it can be used to (i) improve the quality and abundance of biological networks relevant to the cancer research community; (ii) provide a medium for collaboration involving networks; and (iii) facilitate the review and dissemination of networks. We describe innovations addressing the challenges of an online data commons: scalability, data integration, data standardization, control of content and format by authors, and decentralized mechanisms for review. The practical use of NDEx is presented in the context of a novel strategy to foster network-oriented communities of interest in cancer research by adapting methods from academic publishing and social media. Cancer Res; 77(21); e58–61. ©2017 AACR.

15 March 2022 in Viruses
Verified
Journal Article
Open access
PDF file
DMDanielle May
Danielle May
LMLaura Martin-Sancho
Laura Martin-Sancho
VAValesca Anschau
Valesca Anschau
SLSophie Liu
Sophie Liu
RCRachel J. Chrisopulos
Rachel J. Chrisopulos
Kyle RouxKyle Roux
Kyle Roux
The novel coronavirus SARS-CoV-2 is responsible for the ongoing COVID-19 pandemic and has caused a major health and economic burden worldwide. Understanding how SARS-CoV-2 viral proteins behave in host cells can reveal underlying mechanisms of pathogenesis and assist in development of antiviral therapies. Here, the cellular impact of expressing SARS-CoV-2 viral proteins was studied by global proteomic analysis, and proximity biotinylation (BioID) was used to map the SARS-CoV-2 virus–host interactome in human lung cancer-derived cells. Functional enrichment analyses revealed previously reported and unreported cellular pathways that are associated with SARS-CoV-2 proteins. We have established a website to host the proteomic data to allow for public access and continued analysis of host–viral protein associations and whole-cell proteomes of cells expressing the viral–BioID fusion proteins. Furthermore, we identified 66 high-confidence interactions by comparing this study with previous reports, providing a strong foundation for future follow-up studies. Finally, we cross-referenced candidate interactors with the CLUE drug library to identify potential therapeutics for drug-repurposing efforts. Collectively, these studies provide a valuable resource to uncover novel SARS-CoV-2 biology and inform development of antivirals.

23 October 2020 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
ASAkshat Singhal
Akshat Singhal
SCSong Cao
Song Cao
CCChristopher Churas
Christopher Churas
DPDexter Pratt
Dexter Pratt
SFSanto Fortunato
Santo Fortunato
TITrey Ideker
Trey Ideker
Detection of community structure has become a fundamental step in the analysis of biological networks with application to protein function annotation, disease gene prediction, and drug discovery. This recent impact creates a need to make these techniques and their accompanying visualization schemes available to a broad range of biologists. Here we present a service-oriented, end-to-end software framework, CDAPS (Community Detection APplication and Service), that integrates the identification, annotation, visualization, and interrogation of multiscale network communities, accessible within the popular Cytoscape network analysis platform. With novel design principles, CDAPS addresses unmet new challenges, such as identifying hierarchical community structures, comparison of outputs generated from diverse network resources, and easy deployment of new algorithms, to facilitate community-sourced science. We demonstrate that the CDAPS framework can be applied to high-throughput protein-protein interaction networks to gain novel insights, such as the identification of putative new members of known protein complexes.